Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham, et al.
American Journal of Respiratory and Critical Care Medicine (2019) Vol. 201, Iss. 5, pp. 564-574
Open Access | Times Cited: 264

Showing 1-25 of 264 citing articles:

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
Peter M. George, Athol U. Wells, Gisli Jenkins
The Lancet Respiratory Medicine (2020) Vol. 8, Iss. 8, pp. 807-815
Open Access | Times Cited: 993
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
B.J. Moss, Stefan W. Ryter, Iván O. Rosas
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 515-546
Closed Access | Times Cited: 432
An integrated cell atlas of the lung in health and disease
Lisa Sikkema, Ciro Ramírez-Suástegui, Daniel Strobl, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1563-1577
Open Access | Times Cited: 360
Interstitial lung diseases
Marlies Wijsenbeek, Atsushi Suzuki, Toby M. Maher
The Lancet (2022) Vol. 400, Iss. 10354, pp. 769-786
Closed Access | Times Cited: 268
Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
Jincheng Wang, Kaili Hu, Xuanyan Cai, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 1, pp. 18-32
Open Access | Times Cited: 260
Host genetic factors determining COVID-19 susceptibility and severity
Thirumalaisamy P. Velavan, Srinivas Reddy Pallerla, Jule Rüter, et al.
EBioMedicine (2021) Vol. 72, pp. 103629-103629
Open Access | Times Cited: 188
Roles of Macrophage Polarization and Macrophage-Derived miRNAs in Pulmonary Fibrosis
Amit Kishore, Martin Petřek
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 173
TGF‐β as a driver of fibrosis: physiological roles and therapeutic opportunities
Erine H. Budi, Johanna Schaub, Martin Decaris, et al.
The Journal of Pathology (2021) Vol. 254, Iss. 4, pp. 358-373
Open Access | Times Cited: 171
COVID‐19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
Alison E. John, Chitra Joseph, Gisli Jenkins, et al.
Immunological Reviews (2021) Vol. 302, Iss. 1, pp. 228-240
Open Access | Times Cited: 170
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
Anna Duckworth, Michael Gibbons, Richard J. Allen, et al.
The Lancet Respiratory Medicine (2020) Vol. 9, Iss. 3, pp. 285-294
Open Access | Times Cited: 148
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
Jacob E. Michalski, Jonathan S. Kurche, David A. Schwartz
Translational research (2021) Vol. 241, pp. 13-24
Open Access | Times Cited: 105
Genome-wide association study across five cohorts identifies five novel loci associated with idiopathic pulmonary fibrosis
Richard J. Allen, Amy Stockwell, Justin M. Oldham, et al.
Thorax (2022) Vol. 77, Iss. 8, pp. 829-833
Open Access | Times Cited: 80
Interstitial Lung Disease
Toby M. Maher
JAMA (2024) Vol. 331, Iss. 19, pp. 1655-1655
Closed Access | Times Cited: 79
Pulmonary fibrosis: from pathogenesis to clinical decision-making
Thomas Koudstaal, Manuela Funke-Chambour, Michael Kreuter, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 12, pp. 1076-1087
Closed Access | Times Cited: 72
Genetics of chronic obstructive pulmonary disease: understanding the pathobiology and heterogeneity of a complex disorder
Michael H. Cho, Brian D. Hobbs, Edwin K. Silverman
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 5, pp. 485-496
Closed Access | Times Cited: 71
Precision medicine advances in idiopathic pulmonary fibrosis
Τheodoros Karampitsakos, Brenda Juan-Guardela, Argyris Tzouvelekis, et al.
EBioMedicine (2023) Vol. 95, pp. 104766-104766
Open Access | Times Cited: 69
Immunology of human fibrosis
Mallar Bhattacharya, Prakash Ramachandran
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1423-1433
Closed Access | Times Cited: 67
A second update on mapping the human genetic architecture of COVID-19
Masahiro Kanai, Shea J. Andrews, Mattia Cordioli, et al.
Nature (2023) Vol. 621, Iss. 7977, pp. E7-E26
Open Access | Times Cited: 63
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants
Anna L. Peljto, Rachel Z. Blumhagen, Avram Walts, et al.
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 9, pp. 1194-1202
Open Access | Times Cited: 44
Cell-type-specific and disease-associated expression quantitative trait loci in the human lung
Heini M. Natri, Christina B. Azodi, Lance Peter, et al.
Nature Genetics (2024) Vol. 56, Iss. 4, pp. 595-604
Open Access | Times Cited: 23
Interplay between genetics and epigenetics in lung fibrosis
Arvind G Valand, Poojitha Rajasekar, Louise V. Wain, et al.
The International Journal of Biochemistry & Cell Biology (2025), pp. 106739-106739
Open Access | Times Cited: 2
Genetic mechanisms of critical illness in Covid-19
Erola Pairo‐Castineira, Sara Clohisey, Lucija Klarić, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 121
The Roles of Immune Cells in the Pathogenesis of Fibrosis
Enyu Huang, Na Peng, Fan Xiao, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5203-5203
Open Access | Times Cited: 91
Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
Eleanor Valenzi, Tracy Tabib, Anna Papazoglou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top